Stable allosteric binding of m1-toxin to m1 muscarinic receptors

SI Max, JS Liang and LT Potter

Department of Molecular and Cellular Pharmacology, University of Miami School of Medicine, Florida 33101.

m1-Toxin was found to slow the dissociation of [3H]N-methyl-scopolamine (NMS) and [3H]pirenzepine from m1 muscarinic receptors expressed in the membranes of Chinese hamster ovary cells. When toxin-NMS-receptor complexes were formed in membranes and then dissolved in digitonin, or when these complexes were formed in solution, the toxin completely stopped the dissociation of [3H]NMS for 6 hr at 25 degrees C. Toxin- receptor complexes formed in membranes or in solution were also highly stable in solution at 25 degrees, as shown by the ability of the toxin to prevent the binding of [3H]quinuclidinyl benzilate (QNB). [3H] QNB- receptor complexes were equally stable, whereas unliganded soluble receptors lost most of their ability to bind QNB within an hour. Toxin- receptor complexes could be partially dissociated by incubation at 37 degrees in the presence of digitonin and [3H]QNB, and the freed receptors were then labeled. These results demonstrate that m1-toxin binds allosterically and pseudoirreversibly to m1 receptors, and that the toxin can stabilize the outward-facing pocket of m1 receptors which contains and binds competitive antagonists. The allosteric nature of the binding of m1-toxin should prove to be useful for such unusual purposes as stabilizing the binding of readily reversible and/or nonselective ligands specifically to m1 receptors, for purifying labeled or unlabeled receptors by affinity techniques which recognize the toxin, for recognizing receptors with genetically or biochemically altered primary binding sites, and for stabilization of the native conformation of m1 receptors for structural studies.

Volume 44, Issue 6, pp. 1171-1175, 12/01/1993
Copyright © 1993 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				C. Fruchart-Gaillard, G. Mourier, C. Marquer, A. Menez, and D. Servent Identification of Various Allosteric Interaction Sites on M1 Muscarinic Receptor Using 125I-Met35-Oxidized Muscarinic Toxin 7 Mol. Pharmacol., May 1, 2006; 69(5): 1641 - 1651. [Abstract] [Full Text] [PDF]

				A. Kukkonen, M. Perakyla, K. E. O. Akerman, and J. Nasman Muscarinic Toxin 7 Selectivity Is Dictated by Extracellular Receptor Loops J. Biol. Chem., December 3, 2004; 279(49): 50923 - 50929. [Abstract] [Full Text] [PDF]

				G. Mourier, S. Dutertre, C. Fruchart-Gaillard, A. Menez, and D. Servent Chemical Synthesis of MT1 and MT7 Muscarinic Toxins: Critical Role of Arg-34 in Their Interaction with M1 Muscarinic Receptor Mol. Pharmacol., January 1, 2003; 63(1): 26 - 35. [Abstract] [Full Text] [PDF]

				A. Christopoulos and T. Kenakin G Protein-Coupled Receptor Allosterism and Complexing Pharmacol. Rev., June 1, 2002; 54(2): 323 - 374. [Abstract] [Full Text] [PDF]

				J. L. Krajewski, I. M. Dickerson, and L. T. Potter Site-Directed Mutagenesis of m1-Toxin1: Two Amino Acids Responsible for Stable Toxin Binding to M1 Muscarinic Receptors Mol. Pharmacol., October 1, 2001; 60(4): 725 - 731. [Abstract] [Full Text] [PDF]

				J. M. Carsi, H. H. Valentine, and L. T. Potter m2-Toxin: A Selective Ligand for M2 Muscarinic Receptors Mol. Pharmacol., November 1, 1999; 56(5): 933 - 937. [Abstract] [Full Text]

				M. J. Marino, S. T. Rouse, A. I. Levey, L. T. Potter, and P. J. Conn Activation of the genetically defined m1 muscarinic receptor potentiates N-methyl-D-aspartate (NMDA) receptor currents in hippocampal pyramidal cells PNAS, September 15, 1998; 95(19): 11465 - 11470. [Abstract] [Full Text] [PDF]

				S. L. Purkerson and L. T. Potter Use of Antimuscarinic Toxins To Facilitate Studies of Striatal m4 Muscarinic Receptors J. Pharmacol. Exp. Ther., February 1, 1998; 284(2): 707 - 713. [Abstract] [Full Text]